Skip to main content
Top
Published in: European Radiology 10/2005

01-10-2005 | Hepatobiliary-Pancreas

Pineapple juice labeled with gadolinium: a convenient oral contrast for magnetic resonance cholangiopancreatography

Authors: Emmanuel Coppens, Thierry Metens, Catherine Winant, Celso Matos

Published in: European Radiology | Issue 10/2005

Login to get access

Abstract

The aim of our study was to prepare in vitro a pineapple juice (PJ) solution labeled with a minimal gadolinium concentration working as a negative contrast agent in heavily T2-weighted imaging and to assess that solution in vivo as a negative oral contrast agent for magnetic resonance cholangiopancreatography (MRCP). Three PJs were compared in vitro according to their T2. Increasing concentrations of gadolinium (Gd)-DOTA in PJ were assessed in vitro for T2 reduction. Single-shot turbo spin echo T2-weighted MR cholangiopancreatograms were obtained for 35 patients with suspected biliopancreatic duct disease, before and after ingestion of the PJ/Gd-DOTA solution. Signal intensity (SI) measurements of gastroduodenal lumens, pancreatobiliary ducts, and image quality scores were obtained systematically before and after contrast ingestion. The in vitro selected Gd-DOTA concentration in the PJ was 2.76 mmol/l. Ingestion of 180 ml of PJ labeled with 1 ml of Gd-DOTA eliminated efficiently the gastroduodenal SI in MRCP, improving significantly the rates of complete visualization of the pancreatobiliary ducts (P<0.01) and the MRCP image quality scores (P<0.05). All patients easily ingested the contrast solution and found the solution palatable. PJ labeled with gadolinium constituted an efficient and convenient negative oral contrast agent for MRCP.
Literature
1.
go back to reference Barish MA, Yucel EK, Ferrucci JT (1999) Magnetic resonance cholangiopancreatography. N Engl J Med 341:258–264PubMed Barish MA, Yucel EK, Ferrucci JT (1999) Magnetic resonance cholangiopancreatography. N Engl J Med 341:258–264PubMed
2.
go back to reference Devière J, Matos C, Cremer M (1999) The impact of magnetic resonance cholangiopancreatography on ERCP (editorial). Gastrointest Endosc 50:136–140PubMed Devière J, Matos C, Cremer M (1999) The impact of magnetic resonance cholangiopancreatography on ERCP (editorial). Gastrointest Endosc 50:136–140PubMed
3.
go back to reference Holzknecht N, Ganger J, Sackmann M et al (1998) Breath-hold MR cholangiography with snapshot techniques: prospective comparison with endoscopic retrograde cholangiography. Radiology 206:657–664PubMed Holzknecht N, Ganger J, Sackmann M et al (1998) Breath-hold MR cholangiography with snapshot techniques: prospective comparison with endoscopic retrograde cholangiography. Radiology 206:657–664PubMed
4.
go back to reference Matos C, Metens T, Devière J et al (1997) Pancreatic duct: morphologic and functional evaluation with dynamic MR pancreatography after secretin stimulation. Radiology 203:435–441PubMed Matos C, Metens T, Devière J et al (1997) Pancreatic duct: morphologic and functional evaluation with dynamic MR pancreatography after secretin stimulation. Radiology 203:435–441PubMed
5.
go back to reference Hirohashi S, Hirohashi R, Uchida H et al (1997) MR cholangiopancreatography and MR urography: improved enhancement with a negative oral contrast agent. Radiology 203:281–285PubMed Hirohashi S, Hirohashi R, Uchida H et al (1997) MR cholangiopancreatography and MR urography: improved enhancement with a negative oral contrast agent. Radiology 203:281–285PubMed
6.
go back to reference Hiraishi K, Narabayashi I, Fujita O et al (1995) Blueberry juice: preliminary evaluation as an oral contrast agent in gastrointestinal MR imaging. Radiology 194:119–125PubMed Hiraishi K, Narabayashi I, Fujita O et al (1995) Blueberry juice: preliminary evaluation as an oral contrast agent in gastrointestinal MR imaging. Radiology 194:119–125PubMed
7.
go back to reference Papanikolaou N, Karantanas A, Maris T, Gourtsoyannis N (2000) MR cholangiopancreatography before and after oral blueberry juice administration. J Comput Assist Tomogr 24:229–234PubMed Papanikolaou N, Karantanas A, Maris T, Gourtsoyannis N (2000) MR cholangiopancreatography before and after oral blueberry juice administration. J Comput Assist Tomogr 24:229–234PubMed
8.
go back to reference Chan JH, Tsui EY, Yuen MK, Szeto ML, Luk SH, Wong KP, Wong NO (2000) Gadopentate dimeglumine as an oral negative gastrointestinal agent for MRCP. Abdom Imaging 25:405–408PubMed Chan JH, Tsui EY, Yuen MK, Szeto ML, Luk SH, Wong KP, Wong NO (2000) Gadopentate dimeglumine as an oral negative gastrointestinal agent for MRCP. Abdom Imaging 25:405–408PubMed
9.
go back to reference Albrich H, Herfarth HH, Schreyer AG et al (2000) Tasty, cost-effective and healthy: abdominal MRI in patients with IBD with a new oral contrast agent. Gastroenterology 118:A1077 Albrich H, Herfarth HH, Schreyer AG et al (2000) Tasty, cost-effective and healthy: abdominal MRI in patients with IBD with a new oral contrast agent. Gastroenterology 118:A1077
10.
go back to reference Schreyer AG, Herfarth HH, Kikinis R, Seitz J, Schölmerich J, Geissler A, Feuerbach S (2002) 3D modeling and virtual endoscopy of the small bowel based on magnetic resonance imaging in patients with inflammatory bowel disease. Invest Radiol 37:528–533PubMed Schreyer AG, Herfarth HH, Kikinis R, Seitz J, Schölmerich J, Geissler A, Feuerbach S (2002) 3D modeling and virtual endoscopy of the small bowel based on magnetic resonance imaging in patients with inflammatory bowel disease. Invest Radiol 37:528–533PubMed
11.
go back to reference In Den Kleef JJE, Cuppen JJM (1987) RLSQ: T1, T2, and ρ calculations, combining ratios and least squares. Magn Reson Med 5:513–524PubMed In Den Kleef JJE, Cuppen JJM (1987) RLSQ: T1, T2, and ρ calculations, combining ratios and least squares. Magn Reson Med 5:513–524PubMed
12.
go back to reference Meiboom S, Gill D (1958) Modified spin-echo method for measuring nuclear relaxation times. Rev Sci Instrum 29:688–691 Meiboom S, Gill D (1958) Modified spin-echo method for measuring nuclear relaxation times. Rev Sci Instrum 29:688–691
13.
go back to reference Carr HY, Purcell EM (1954) Effects of diffusion on free precession in nuclear magnetic resonance experiments. Phys Rev 94:630–638 Carr HY, Purcell EM (1954) Effects of diffusion on free precession in nuclear magnetic resonance experiments. Phys Rev 94:630–638
14.
go back to reference Cappeliez O, Delhaye M, Devière J et al (2000) Chronic pancreatitis: evaluation of pancreatic exocrine function with MR pancreatography after secretin stimulation. Radiology 215:358–364PubMed Cappeliez O, Delhaye M, Devière J et al (2000) Chronic pancreatitis: evaluation of pancreatic exocrine function with MR pancreatography after secretin stimulation. Radiology 215:358–364PubMed
15.
go back to reference Mathur-De Vré R, Lemort M (1995) Invited review: biophysical properties and clinical applications of magnetic resonance imaging contrast agents. Br J Radiol 68:225–247PubMed Mathur-De Vré R, Lemort M (1995) Invited review: biophysical properties and clinical applications of magnetic resonance imaging contrast agents. Br J Radiol 68:225–247PubMed
16.
go back to reference Van Gansbeke D, Metens TM, Matos C, Nicaise N, Gay F, Raeymaekers H, Struyven J (1997) Effect of AMI-25 on liver vessels and tumors on T1-weighted turbo-field-echo images: implications for tumor characterization. J Magn Reson Imaging 7:482–489PubMed Van Gansbeke D, Metens TM, Matos C, Nicaise N, Gay F, Raeymaekers H, Struyven J (1997) Effect of AMI-25 on liver vessels and tumors on T1-weighted turbo-field-echo images: implications for tumor characterization. J Magn Reson Imaging 7:482–489PubMed
17.
go back to reference Punwani S, Gillams AR, Lees WR (2003) Non-invasive quantification of pancreatic exocrine function using secretin-stimulated MRCP. Eur Radiol 13:273–276PubMed Punwani S, Gillams AR, Lees WR (2003) Non-invasive quantification of pancreatic exocrine function using secretin-stimulated MRCP. Eur Radiol 13:273–276PubMed
18.
go back to reference Sujita R, Nomiya T (2002) Disappearance of the common bile duct signal caused by oral negative contrast agent on MR-cholangiopancreatography. J Comput Assist Tomogr 26:448–450PubMed Sujita R, Nomiya T (2002) Disappearance of the common bile duct signal caused by oral negative contrast agent on MR-cholangiopancreatography. J Comput Assist Tomogr 26:448–450PubMed
19.
go back to reference Karantanas AH, Papanikolaou N, Kalef-Ezra J, Challa A, Gourtsoyiannis N (2000) Blueberry juice used per os in upper abdominal MR imaging: composition and initial clinical data. Eur Radiol 10:909–913PubMed Karantanas AH, Papanikolaou N, Kalef-Ezra J, Challa A, Gourtsoyiannis N (2000) Blueberry juice used per os in upper abdominal MR imaging: composition and initial clinical data. Eur Radiol 10:909–913PubMed
20.
go back to reference Riordan RD, Khonsari M, Jeffries J, Maskell GF, Cook PG (2004) Pineapple juice as negative oral contrast agent in magnetic resonance cholangiopancreatography: a preliminary evaluation. Br J Radiol 77:991–999PubMed Riordan RD, Khonsari M, Jeffries J, Maskell GF, Cook PG (2004) Pineapple juice as negative oral contrast agent in magnetic resonance cholangiopancreatography: a preliminary evaluation. Br J Radiol 77:991–999PubMed
21.
go back to reference Patak MA, Weishaupt D, Fröhlich JM, Debatin JF (1999) Sequential fast 3D MRI following oral ingestion of Gd-DOTA: a new means to assess intestinal transit time. J Magn Reson Imaging 10:474–476PubMed Patak MA, Weishaupt D, Fröhlich JM, Debatin JF (1999) Sequential fast 3D MRI following oral ingestion of Gd-DOTA: a new means to assess intestinal transit time. J Magn Reson Imaging 10:474–476PubMed
22.
go back to reference Luboldt W, Kienzler D, Seemann M et al (2000) Synergistic effect between iron and gadolinium in MRI. J Magn Reson Imaging 12:358–362PubMed Luboldt W, Kienzler D, Seemann M et al (2000) Synergistic effect between iron and gadolinium in MRI. J Magn Reson Imaging 12:358–362PubMed
23.
go back to reference Allard M, Doucet D, Kien P, Bonnemain B, Caillé JM (1988) Experimental study of DOTA-gadolinium: pharmacokinetics and pharmacologic properties. Invest Radiol 23:S271–S274PubMed Allard M, Doucet D, Kien P, Bonnemain B, Caillé JM (1988) Experimental study of DOTA-gadolinium: pharmacokinetics and pharmacologic properties. Invest Radiol 23:S271–S274PubMed
24.
go back to reference Schwizer W, Fraser R, Maecke H, Siebold K, Funck R, Fried M (1994) Gd-DOTA as a gastrointestinal contrast agent for gastric emtpying measurements with MRI. Magn Reson Med 31:388–393PubMed Schwizer W, Fraser R, Maecke H, Siebold K, Funck R, Fried M (1994) Gd-DOTA as a gastrointestinal contrast agent for gastric emtpying measurements with MRI. Magn Reson Med 31:388–393PubMed
25.
go back to reference Kunz P, Crelier GR, Schwizer W, Borovicka J, Kreiss C, Fried M, Boesiger P (1998) Gastric emptying and motility: assessment with MR imaging—preliminary observations. Radiology 207:33–40PubMed Kunz P, Crelier GR, Schwizer W, Borovicka J, Kreiss C, Fried M, Boesiger P (1998) Gastric emptying and motility: assessment with MR imaging—preliminary observations. Radiology 207:33–40PubMed
26.
go back to reference Schmid MR, Hany TF, Knesplova L, Schlumpf R, Debatin JF (1999) 3D MR gastrography: exoscopic an endoscopic analysis of the stomach. Eur Radiol 9:73–77PubMed Schmid MR, Hany TF, Knesplova L, Schlumpf R, Debatin JF (1999) 3D MR gastrography: exoscopic an endoscopic analysis of the stomach. Eur Radiol 9:73–77PubMed
27.
go back to reference Lauenstein TC, Goehde SC, Debatin JF (2002) Fecal tagging: MR colonography without colonic cleansing. Abdom Imaging 27:410–417PubMed Lauenstein TC, Goehde SC, Debatin JF (2002) Fecal tagging: MR colonography without colonic cleansing. Abdom Imaging 27:410–417PubMed
28.
go back to reference Tweedle MF (1992) Physicochemical properties of Gadoteridol and other magnetic resonance contrast agents. Invest Radiol 27:S2–S6PubMed Tweedle MF (1992) Physicochemical properties of Gadoteridol and other magnetic resonance contrast agents. Invest Radiol 27:S2–S6PubMed
29.
go back to reference Cacheris WP, Quay SC, Rocklage SM (1990) The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Reson Imaging 8:467–481PubMed Cacheris WP, Quay SC, Rocklage SM (1990) The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Reson Imaging 8:467–481PubMed
30.
go back to reference Weinmann H, Brasch R, Press W, Wesbey G (1984) Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Am J Roentgenol 142:619–624 Weinmann H, Brasch R, Press W, Wesbey G (1984) Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Am J Roentgenol 142:619–624
Metadata
Title
Pineapple juice labeled with gadolinium: a convenient oral contrast for magnetic resonance cholangiopancreatography
Authors
Emmanuel Coppens
Thierry Metens
Catherine Winant
Celso Matos
Publication date
01-10-2005
Publisher
Springer-Verlag
Published in
European Radiology / Issue 10/2005
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-005-2835-5

Other articles of this Issue 10/2005

European Radiology 10/2005 Go to the issue